Electra Therapeutics is seeking an IPO listing on Nasdaq, retaining TD Cowen as joint bookrunner and filing S-1.

The entities involved

• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• ADARx Pharmaceuticals, Inc. is seeking a public listing via IPO on Nasdaq, having filed the S-1 registration statement with the SEC and appointing Morgan Stanley as joint bookrunner.Sep 4
• BMB is filing an IPO with the SEC and proposing a listing on the NYSE, with Morgan Stanley and Broadridge Financial Solutions acting as joint bookrunners.Aug 28
• Amaero Inc. filed an S-1 registration statement with the SEC to seek an Initial Public Offering listing on Nasdaq, with Baird running the deal.Aug 28
• Offering filed with SEC and declared effective for Southern Cross Acquisition II Corp., with IPO expected on Nasdaq Capital Market.Aug 26
• Aardvark Therapeutics filed IPO documents with the SEC.Wed 22:47